EnhiA.01533.a
ADP-ribosylation factor, putative
CENTER ID:
EnhiA.01533.a
ORGANISM:
Entamoeba histolytica HM-1:IMSS
ASSOCIATED DISEASE:
Amoebic dysentery
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
False
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIIB
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
EnhiA.01533.a.A1.PS00671
Full length( EnhiA.01533.a )
info
1
174
PS00671
EnhiA.01533.a.A1.PS00677
Full length( EnhiA.01533.a )
info
1
174
PS00677
Structures
4Y0V
DEPOSITED: 2/6/2015
DETERMINATION: XRay
CLONE: EnhiA.01533.a.A1.GE28433
PROTEIN: EnhiA.01533.a.A1.PS00671
4YLG
DEPOSITED: 3/5/2015
DETERMINATION: XRay
CLONE: EnhiA.01533.a.A1.GE28433
PROTEIN: EnhiA.01533.a.A1.PS00671
Publications by SSGCID
Structure of an ADP-ribosylation factor, ARF1, from Entamoeba histolytica bound to Mg(2+)-GDP.
Clifton MC, Edwards TE, Myler PJ, Sankaran B, Serbzhinskiy DA, Staker BL
Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. - 2015
volume 71, issue Pt 5, pages 594-9
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MGSWLSKLLG KKEMRILMVG LDAAGKTSIL YKLKLGEIVT TIPTIGFNVE TVEYKNISFT VWDVGGQDKI RPLWRHYYQN TQAIIFVVDS NDRDRIGEAR EELMKMLNED EMRNAILLVF ANKHDLPQAM SISEVTEKLG LQTIKNRKWY CQTSCATNGD GLYEGLDWLA DNLK
NT Sequence
ATGGGAAGTT GGTTAAGTAA ATTACTTGGA AAGAAAGAAA TGAGAATTTT GATGGTAGGA CTTGATGCTG CCGGTAAAAC TTCAATTCTT TATAAGTTAA AACTTGGAGA AATTGTCACT ACTATTCCAA CTATTGGATT TAATGTAGAA ACTGTTGAAT ATAAGAATAT TTCCTTTACT GTTTGGGATG TAGGAGGACA AGATAAAATT AGACCATTAT GGAGACATTA TTATCAAAAT ACTCAAGCAA TTATTTTTGT AGTTGATTCT AATGATAGAG ACCGTATTGG AGAAGCACGT GAAGAATTAA TGAAAATGTT AAATGAAGAT GAGATGAGAA ATGCTATTTT GCTTGTTTTT GCTAATAAAC ATGATTTACC ACAAGCTATG TCTATTTCTG AAGTTACAGA AAAACTTGGA TTACAAACAA TTAAGAATCG TAAATGGTAT TGTCAAACAT CATGTGCAAC TAATGGTGAT GGACTTTATG AGGGTCTTGA TTGGCTTGCT GATAATCTCA AA
Details for EnhiA.01533.a.A1.PS00671
PURIFICATION DATe:
7/6/2010
CONCENTRATION:
13.45mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
6
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
100
Details for EnhiA.01533.a.A1.PS00677
PURIFICATION DATe:
7/6/2010
CONCENTRATION:
54.37mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
5
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
100